[1]郭海涵 李述峰 曹威.无导线心脏起搏器的研究现状与展望[J].心血管病学进展,2022,(11):973.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.003]
　GUO Haihan,LI Shufeng,CAO Wei.Status and Prospect of Leadless Cardiac Pacemaker[J].Advances in Cardiovascular Diseases,2022,(11):973.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.003]
点击复制

无导线心脏起搏器的研究现状与展望()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2022年11期
页码:
973
栏目:
综述
出版日期:
2022-11-25

文章信息/Info

Title:
Status and Prospect of Leadless Cardiac Pacemaker
作者:
郭海涵1 李述峰2 曹威1; 2
(1.哈尔滨医科大学研究生院,黑龙江 哈尔滨 150086;2.哈尔滨医科大学附属第二医院心血管内科,黑龙江 哈尔滨 150086)
Author(s):
GUO Haihan1; LI Shufeng2; CAO Wei 1; 2
(1.Harbin Medical University Graduate School,Harbin 150086,Heilongjiang,China; 2.Department of Cardiology,The Second Affiliated Hospital of Harbin Medical University,Harbin 150086,Heilongjiang,China)
关键词:
无导线心脏起搏器; 并发症; 心动过缓; 心脏再同步化治疗
Keywords:
Leadless cardiac pacemaker; Complication; Bradycardia; Cardiac resynchronization therapy
DOI:
10.16806/j.cnki.issn.1004-3934.2022.11.003
摘要:
心脏起搏器已在临床工作中广泛应用，从非生理性起搏到生理性起搏，从有导线起搏到无导线起搏，起搏器的发展有目共睹。起搏器在缓慢型心律失常的患者中得到广泛应用。新型无导线起搏器能减少起搏器相关并发症，在临床中，相较于传统起搏器具有其显著优势。然而，其仍存在起搏方式单一，不能进行生理性起搏，以及拔除更换上经验不足等问题。相信随着无导线起搏的发展，迈入真正的无导线时代并非天方夜谭。现就无导线心脏起搏器的研究现状与展望做一综述。
Abstract:
Cardiac pacemaker has been widely used in the clinical work . From non-physiological pacing to physiological pac ing,from lead pac ing to leadless pac ing,the development of pacemaker is obvious to all. Pacemaker is widely used in patients with bradyarrhythmias. The new leadless pacemaker reduces pacemaker-related complications and offers significant advantages over conventional pacemaker in the clinic. However,there are still problems such as a single pacing method,the inability to perform physiological pacing,and insufficient experience in removal and replacement. It is believed that with the development of wireless pacing,it is not a fantasy to enter the real wireless era. The research status and prospects of leadless cardiac pacemaker is reviewed i n this paper

参考文献/References:

[1]朱琳,郭静,李鹤飞,等. 永久性心脏起搏器植入相关并发症及影响因素分析[J]. 三峡大学学报(自然科学版),2017,39(A02):119-121.

[2]钟洁敏,张幼聪. 永久心脏起搏器植入常见并发症临床分析[J]. 中西医结合心血管病杂志（电子版）,2018,6(3):55.

[3]信满坤,张抒扬. 双腔永久起搏器置入术后长期并发症的研究进展[J]. 心肺血管病杂志,2019,38(10):1066-1070.

[4]Kirkfeldt RE,Johansen JB,Nohr EA,et al. Complications after cardiac implantable electronic device implantations:an analysis of a complete,nationwide cohort in Denmark[J]. Eur Heart J,2014,35(18):1186-1194.

[5]Cantillon DJ,Exner DV,Badie N,et al. Complications and health care costs associated with transvenous cardiac pacemakers in a nationwide assessment[J]. JACC Clin Electrophysiol,2017,3(11):1296-1305.

[6]Tobin K,Stewart J,Westveer D,et al. Acute complications of permanent pacemaker implantation:their financial implication and relation to volume and operator experience[J]. A m J Cardiol ,2000,85(6):774-776,A9.

[7]Spickler JW,Rasor NS,Kezdi P,et al. Totally self-contained intracardiac pacemaker[J]. J Electrocardiol ,1970,3(3-4):325-331.

[8]Reddy VY,Exner DV,Cantillon DJ,et al. Percutaneous implantation of an entirely intracardiac leadless pacemaker [J]. N Engl J Med,2015,373(12):1125-1135.

[9]Reynolds D,Duray GZ,Omar R,et al. A leadless intracardiac transcatheter pacing system[J]. N Engl J Med,2016,374(6):533-541.

[10]Chinitz L,Ritter P,Khelae SK,et al. Accelerometer-based atrioventricular synchronous pacing with a ventricular leadless pacemaker:results from the Micra atrioventricular feasibility studies[J]. Heart Rhythm,2018,15(9):1363-1371.

[11]Knops RE,Tjong FV,Neuzil P,et al. Chronic performance of a leadless cardiac pacemaker:1-year follow-up of the LEADLESS trial[J]. J Am Coll Cardiol,2015,65(15):1497-1504.

[12]Reddy VY,Knops RE,Sperzel J,et al. Permanent leadless cardiac pacing:results of the LEADLESS trial[J]. Circulation,2014,129(14):1466-1471.

[13]Sperzel J,Defaye P,Delnoy PP,et al. Primary safety results from the LEADLESS observational study[J]. Europace,2018,20(9):1491-1497.

[14]Tjong FVY,Beurskens NEG,Neuzil P,et al. The learning curve associated with the implantation of the Nanostim leadless pacemaker[J]. J Interv Card Electrophysiol,2018,53(2):239-247.

[15]Duray GZ,Ritter P,El-Chami M,et al. Long-term performance of a transcatheter pacing system:12-month results from the Micra transcatheter pacing study[J]. Heart Rhythm,2017,14(5):702-709 .

[16]Roberts PR,Clementy N,Al Samadi F,et al. A leadless pacemaker in the real-world setting:the Micra Transcatheter Pacing System Post-Approval Registry[J]. Heart Rhythm,2017,14(9):1375-1379.

[17]El-Chami MF,Al-Samadi F,Clementy N,et al. Updated performance of the Micra transcatheter pacemaker in the real-world setting:a comparison to the investigational study and a transvenous historical control[J]. Heart Rhythm,2018,15(12):1800-1807.

[18]Lamas GA,Ellenbogen KA. Evidence base for pacemaker mode selection:from physiology to randomized trials[J]. Circulation,2004,109(4):443-451.

[19]Chinitz L,Ritter P,Khelae SK,et al. Accelerometer-based atrioventricular synchronous pacing with a ventricular leadless pacemaker:results from the Micra atrioventricular feasibility studies[J]. Heart Rhythm,2018,15(9):1363-1371.

[20]Steinwender C,Khelae SK,Garweg C,et al. Atrioventricular synchronous pacing using a leadless ventricular pacemaker:results from the MARVEL 2 study[J]. JACC Clin Electrophysiol,2020,6(1):94-106.

[21]Tjong FVY,Knops RE,Udo EO,et al. Leadless pacemaker versus transvenous single-chamber pacemaker therapy:a propensity score-matched analysis [J]. Heart Rhythm,2018,15(9):1387-1393.

[22]Zucchelli G,Tolve S,Barletta V,et al. Comparison between leadless and transvenous single-chamber pacemaker therapy in a referral centre for lead extraction[J]. J Interv Card Electrophysiol,2021,61(2):395-404.

[23]Soejima K,Edmonson J,Ellingson ML,et al. Safety evaluation of a leadless transcatheter pacemaker for magnetic resonance imaging use[J]. Heart Rhythm,2016,13(10):2056-2063.

[24]Koay A,Khelae S,Wei KK,et al. Treating an infected transcatheter pacemaker system via percutaneous extraction[J]. HeartRhythm Case Rep,2016,2(4):360-362.

[25]El-Chami MF,Johansen JB,Zaidi A,et al. Leadless pacemaker implant in patients with pre-existing infections:results from the Micra postapproval registry[J]. J Cardiovasc Electrophysiol,2019,30(4):569-574.

[26]Zucchelli G,Barletta V,Della Tommasina V,et al. Micra pacemaker implant after cardiac implantable electronic device extraction:feasibility and long-term outcomes[J]. Europace,2019,21(8):1229-1236.

[27]Kypta A,Blessberger H,Kammler J,et al. Leadless cardiac pacemaker implantation after lead extraction in patients with severe device infection[J]. J Cardiovasc Electrophysiol,2016,27(9):1067-1071.

[28]Clementy N,Coelho R,Veltmann C,et al. Leadless pacemakers in critically ill patients requiring prolonged cardiac pacing:a multicenter international study[J]. J Cardiovasc Electrophysiol,2021,32(9):2522-2527.

[29]Garweg C,Vandenberk B,Foulon S,et al. Leadless pacemaker for patients following cardiac valve intervention[J]. Arch Cardiovasc Dis,2020,113(12):772-779.

[30]Siddeek H,Jimenez E,Ambrose M,et al. Pediatric Micra leadless pacemaker implantation via the internal jugular and femoral vein:a single-center,US experience[J]. Future Cardiol,2021,17(6):1116-1122.

[31]Mahapatra S,Bybee KA,Bunch TJ,et al. Incidence and predictors of cardiac perforation after permanent pacemaker placement[J]. Heart Rhythm,2005,2(9):907-911.

[32]Tolosana JM,Guasch E,San Antonio R ,et al. Very high pacing thresholds during long-term follow-up predicted by a combination of implant pacing threshold and impedance in leadless transcatheter pacemakers[J]. J Cardiovasc Electrophysiol,2020,31(4):868-874.

[33]Omdahl P,Eggen MD,Bonner MD,et al. Right ventricular anatomy can

accommodate multiple Micra transcatheter pacemakers[J]. Pacing Clin Electrophysiol,2016,39(4):393-397.

[34]Bhatia NK,Kiani S,Merchant FM,et al. Life cycle management of Micra transcatheter pacing system:data from a high-volume center[J]. J Cardiovasc Electrophysiol,2021,32(2):484-490.

[35]El-Chami MF,Shinn T,Bansal S,et al. Leadless pacemaker implant with concomitant atrioventricular node ablation:experience with the Micra transcatheter pacemaker[J]. J Cardiovasc Electrophysiol,2021,32(3):832-841.

[36]Mitacchione G,Schiavone M,Gasperetti A,et al. Micra-AV leadless pacemaker and atrioventricular (dys)synchrony:a stepwise process[J]. Pacing Clin Electrophysiol,2021,44(10):1738-1742.

[37]Vatterott PJ,Eggen MD,Hilpisch KE,et al. Implant,performance,and retrieval of an atrial leadless pacemaker in sheep[J]. Heart Rhythm,2021,18(2):288-296.

[38]Reddy VY,Miller MA,Neuzil P,et al. Cardiac resynchronization therapy with wireless left ventricular endocardial pacing:the SELECT-LV study[J]. J Am Coll Cardiol,2017,69(17):2119-2129.

[39]Auricchio A,Delnoy PP,Butter C,et al. Feasibility,safety,and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients:results of the wireless stimulation endocardially for CRT(WiSE-CRT) study[J]. Europace,2014,16(5):681-688.

[40]Sidhu BS,Sieniewicz B,Gould J,et al. Leadless left ventricular endocardial pacing for CRT upgrades in previously failed and high-risk patients in comparison with coronary sinus CRT upgrades[J]. Europace,2021,23(10):1577-1585.

[41]Carabelli A,Jabeur M,Jacon P,et al. European experience with a first totally leadless cardiac resynchronization therapy pacemaker system[J]. Europace,2021,23(5):740-747.

[42]Mondésert B,Dubuc M,Khairy P,et al. Combination of a leadless pacemaker and subcutaneous defibrillator:first in-human report[J]. HeartRhythm Case Rep ,2015,1(6):469-471.

[43]Ng JB,Chua K,Teo WS. Simultaneous leadless pacemaker and subcutaneous implantable cardioverter-defibrillator implantation—When vascular options have run out[J]. J Arrhythm,2018,35(1):136-138.

[44]Tjong FVY,Brouwer TF,Kooiman KM,et al. Communicating antitachycardia pacing-enabled leadless pacemaker and subcutaneous implantable defibrillator[J]. J Am Coll Cardiol ,2016,67(15):1865-1866.

[45]Zhang S,Zhou XH,Gold MR . Left bundle branch pacing:JACC review topic of the week[J]. J Am Coll Cardiol,2019,74(24):3039-3049.

相似文献/References:

[1]徐奕 杨跃进.经桡动脉冠状动脉介入术后骨筋膜室综合征的防治[J].心血管病学进展,2020,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.001]
　XU Yi,YANG Yuejin.Prevention and Treatment of Osteofascial Compartment Syndrome after Transradial Percutaneous Coronary Intervention[J].Advances in Cardiovascular Diseases,2020,(11):1.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.001]
[2]于春鑫 孙姣 孙源君 尹晓盟.心房颤动导管消融相关心房食管瘘的研究进展[J].心血管病学进展,2020,(7):691.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.005]
　YU Chunxin,SUN Jiao,SUN Yuanjun,et al.Atrioesophageal Fistula Associated with Catheter Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2020,(11):691.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.005]
[3]李亚会 黄从新.左心耳封堵术常见并发症及其防治[J].心血管病学进展,2021,(5):408.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.006]
　LI YahuiHUANG Congxin.Common Complications of Left Atrial Appendage Occlusion and Its Prevention and Treatment[J].Advances in Cardiovascular Diseases,2021,(11):408.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.006]
[4]喻瑜 牛红霞 华伟.心血管植入型电子器械囊袋血肿的管理及预防[J].心血管病学进展,2022,(8):684.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.004]
　YU Yu,NIU Hongxia,HUA Wei.Management of Prevention of Cardiovascular Implantable Electronic Device Pocket Hematoma[J].Advances in Cardiovascular Diseases,2022,(11):684.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.004]
[5]杜淦 曹钰尉 唐炯 胥雪莲.左束支起搏研究进展[J].心血管病学进展,2022,(8):687.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.005]
　DU Gan CAO Yuwei TANG Jiong XU Xuelian.Left Bundle Branch Pacing[J].Advances in Cardiovascular Diseases,2022,(11):687.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.005]
[6]马娟 范洁.无导线起搏器与传统起搏器并发症比较[J].心血管病学进展,2022,(9):819.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.013]
　MA Juan,FAN Jie.Comparison of Complications Between Leadless Cardiac Pacemaker and Traditional Pacemaker[J].Advances in Cardiovascular Diseases,2022,(11):819.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.013]
[7]吕华胜 汤宝鹏 芦颜美.心房颤动导管消融后并发症的性别差异研究进展[J].心血管病学进展,2022,(11):961.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.001]
　LV Huasheng,TANG Baopeng,LU Yanmei.Gender Differences in Complications After Catheter Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(11):961.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.001]
[8]胡正 陈祥 洲陈静.经导管主动脉瓣置换术后冠状动脉阻塞的研究进展[J].心血管病学进展,2023,(5):402.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.005]
　HUZheng,CHENXiangzhou,CHENJing.Coronary Occlusion of Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2023,(11):402.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.005]
[9]张帆 黄从新.心房颤动冷冻球囊消融常见并发症及其防治[J].心血管病学进展,2023,(8):673.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.001]
　ZHANG Fan,HUANG Congxin.Common Complications and Prevention of Cryoballoon Ablation of Atrial Fibrillation and Its Prevention[J].Advances in Cardiovascular Diseases,2023,(11):673.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.001]
[10]王歆烨,崔萌萌,赵刚,等.司美格鲁肽治疗2型糖尿病心血管并发症的研究进展[J].心血管病学进展,2023,(8):733.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.014]
　WANG Xinye,CUI Mengmeng,ZHAO Gang,et al.Treatment with Semaglutide in Cardiovascular Complications of?ype 2 Diabetes[J].Advances in Cardiovascular Diseases,2023,(11):733.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.014]

更新日期/Last Update: 2023-01-31